Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction by Maike Knorr et al.
MINI REVIEW ARTICLE
published: 14 August 2014
doi: 10.3389/fphys.2014.00295
Interplay of NK cells and monocytes in vascular
inflammation and myocardial infarction
Maike Knorr , Thomas Münzel and Philip Wenzel*
Department of Medicine 2 and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany
Edited by:
Christian Albert Gleissner, University
of Heidelberg, Germany
Reviewed by:
Dan Predescu, Rush University, USA
Giuseppe Pignataro, Federico II
University Of Naples, Italy
*Correspondence:
Philip Wenzel, Department of
Medicine 2 and Center for
Thrombosis and Hemostasis,
University Medical Center Mainz,
Langenbeckstr. 1, 55131 Mainz,
Germany
e-mail: wenzelp@uni-mainz.de
Inflammatory monocytes and macrophages have been identified as key players in the
pathogenesis of atherosclerosis, arterial hypertension, and myocardial infarction (MI). They
become powerful mediators of vascular inflammation through their capacity to secrete
and induce the production of proinflammatory cytokines, chemokines and adhesion
molecules and through the production of reactive oxygen species mainly via their NADPH
oxidase. Importantly, a crosstalk exists between NK cells and monocytes that works via
a feedforwad amplification loop of T-bet/Interferon-gamma/interleukin-12 signaling, that
causes mutual activation of both NK cells and monocytes and that fosters recruitment
of inflammatory cells to sites of inflammation. Recently, we have discovered that this
crosstalk is crucial for the unrestricted development of angiotensin II (ATII) induced
vascular injury in arterial hypertension, the most important risk factor for atherosclerosis
and cardiovascular disease worldwide. In this review, we will also discuss possible
implications of this interplay between NK cells and monocytes for the pathogenesis of
coronary atherosclerosis and myocardial infarction and potential therapeutic options.
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ROLE OF MONOCYTES/MACROPHAGES IN
ATHEROSCLEROSIS, CORONARY ARTERY DISEASE, ACUTE
CORONARY SYNDROME AND VASCULAR INFLAMMATION
Myocardial infarction (MI) is one of the leading causes of mor-
bidity andmortality in western societies (Hausenloy, 2009).Many
risk factors like arterial hypertension, diabetes mellitus or lipid
metabolism disorders can result alone or in combination in steno-
sis of the coronary blood vessels. Within the last years multiple
genetic factors and the influence of the immune system were
described in the pathogenesis of atherosclerosis. Innate immu-
nity pathways have long been suspected to contribute to the
initiation and progression of atherosclerosis (Shibata and Glass,
2009). Hence, atherosclerosis and its sequela can be consid-
ered as both a chronic inflammatory disease and as a metabolic
disorder.
THE SEQUENCE OF NEUTROPHILS AND MONOCYTES
Polymorphonuclear leukocytes (PMNs, reflecting mainly neu-
trophil granulocytes) dominate the initial influx of leukocytes to
sites of acute infection and inflammation followed by emigration
of monocytes. In 1968 Ward et al. described first that there exists
a causal link between initial extravasation of PMNs followed by
later emigration of monocytes (Ward, 1968). Gallin et al. identi-
fied that in patients who suffer from specific granule deficiency
had a reduced effect on chemotactic effect on monocytes (Gallin
et al., 1982). In different mouse studies it seemed that recruited
PMNs trigger monocyte recruitment by releasing soluble fac-
tors (Doherty et al., 1988; Fillion et al., 2001; Janardhan et al.,
2006). Different granule proteins of PMNs, for example cathepsin
and human neutrophil peptide 1–3, with monocyte chemotactic
activity could be identified (Territo et al., 1989; Chertov et al.,
1997).
Peripheral blood monocytes are a heterogeneous group of
circulating leukocytes, which can be distinguished in different
subsets with diverse functions. These subsets have different phe-
notypes in mice and humans (Tacke et al., 2007; Ley et al.,
2011). Geissmann et al. identified two subsets in murine blood
that can be discriminated by the receptor for the chemokine
fractalkine, the CX3CR1: The short lived CX3CRlo1 CCR2
+GR1+
(more specifically, Ly6Chi) cells, which are pro-inflammatory, are
chemoattracted by MCP-1 and migrate to sites of inflamma-
tion and a CX3CRhi1 CCR2
−GR1− subset (Ly6Clo) not attracted
by inflamed tissues, that was later termed reparative. The
CX3CRlo1 CCR2
+GR1+ cells correspond to CD14hiCD16− mono-
cytes, whereas the latter were equivalent to CD14loCD16+
monocytes in humans (Geissmann et al., 2003). They express
different levels of chemokine receptors and cytokines depend-
ing on their function (Weber et al., 2000). CD14hiCD16−
monocytes produce high levels of pro-inflammatory cytokines
such as tumor necrosis factor alpha (TNF-α) and low lev-
els of anti-inflammatory cytokines such as IL-10. In contrast,
CD14loCD16+ monocytes have been shown to produce high lev-
els of IL-10 and low of TNF-α (Patino et al., 2000; Belge et al.,
2002; Skrzeczynska-Moncznik et al., 2008). Shortly after acute
MI in patients CD14hiCD16+ monocytes were increased and
decreased at day 7 (Tsujioka et al., 2009). All subsets of mono-
cytes can differentiate into macrophages after being recruited
to lesions and then can be found in all tissues, where they
have functional diversity (Wynn et al., 2013). The macrophages
can be divided in M1 and M2 macrophages, M1 are activated
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by interferon gamma (IFN-γ) and have a more inflamma-
tory phenotype by producing nitrogen intermediaries and pro-
inflammatory cytokines (IL-1β and TNF-α) and participating
in TH1 polarization. M2 macrophages act more in an anti-
inflammatory way (IL-12low and IL-10high) and participate in
TH2 responses (Murray and Wynn, 2011). In mouse models
of atherosclerosis, an infiltration of M2 macrophages in the
early lesions could been identified, whereas M1 macrophages
were predominant in advanced stages of the disease (Khallou-
Laschet et al., 2010). Interestingly, it was recently shown, that
experimental MI accelerates atherosclerosis in high fat diet fed
ApoE−/− mice driven by inflammatory Ly6Chi monocytes (Dutta
et al., 2012). This study provided a mechanistic explanation
for the fact that history of MI is a risk factor for cardiovas-
cular disease. It also highlightens the essential role of mono-
cyte driven vascular inflammation for coronary atherosclerosis
and MI.
THE INFLAMMATORY RESPONSE IN CARDIAC ISCHEMIC INJURY
Immediately after cardiac ischemia, different inflammatory sig-
nals recruit neutrophils to the infarct zone within 24 h, and
monocytes/macrophages shortly thereafter (Figure 1). These
homed leukocytes degrade extracellular matrix constituents and
macromolecules released by injured cells. Neutrophils play an
important role in the clearance of dead cardiac myocytes and
their debris (Nahrendorf et al., 2007), release oxidants (mainly
via their phagocyte type NADPH oxidase) and proteases and
secrete mediators for inflammatory cell recruitment. Romson
and coworkers could show in 1983, that depletion of these neu-
trophils in animals undergoing reperfused MI led to a marked
decrease in infarct size, suggesting that a significant amount
of myocardial injury induced by coronary artery occlusion fol-
lowed by reperfusion may be neutrophil-dependent (Romson
et al., 1983; Litt et al., 1989). The detrimental effects seem to
be mediated by ICAM-1-dependent neutrophil-cardiomyocyte
adhesion, a primary ligand of Mac-1 and CD11b/CD18 inte-
grin. In an ICAM-1 ko mouse model it could be shown
that there was less myocardial injury after MI (Metzler et al.,
2001). Infarcted hearts modulate their chemokine expression
profile over time, and sequentially and actively recruit Ly6Chi
and Ly6Clow monocytes. Ly6Chi monocytes dominate early
and exhibit phagocytic, proteolytic and inflammatory func-
tions. In the later process Ly6Clow monocytes predominate.
Consequently, Ly6Chi monocytes digest damaged tissue, whereas
Ly6Clow promote healing via myofibroblast accumulation, angio-
genesis and deposition of collagen (Nahrendorf et al., 2007).
In 2010 Panizzi et al. found that Ly-6Chi monocytosis dis-
turbs resolution of inflammation in murine infarcts and con-
sequently enhances left ventricular remodeling (Panizzi et al.,
2010).
FIGURE 1 | Phases of the inflammatory response in ischemic injury. After
ischemic injury, e.g., myocardial infarction, a sequence of inflammatory events
has been proposed. As first line of defense, neutrophil granulocytes rush in
clearing debris and paving the way for monocytosis by specific chemotactic
patterns (Soehnlein et al., 2008; Wantha et al., 2013). Neutrophils are followed
by inflammatory Ly6ChiCCR2+CX3CR−1 monocytes (day 2–4) which can either
transdifferentiate into or are replaced by reparative Ly6Clow/−CCR2−CX3CR+1
monocytes (day 5–10). Both subsets can give rise to macrophages and/or
dendritic cells (starting from d7 to 10) or modulate the activity of those cells
already residing in the heart. Alternatively, those macrophages or dendritic
cells which are essential for post ischemic remodeling and scar formation can
also emerge from tissue resident precursors or bone-marrow-lineage
independent macrophages. How natural killer cells crosstalk to those innate
cells in the setting of MI is poorly understood.
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After recruitment in the infarcted territory, monocytes
may differentiate into macrophages. Local upregulation of
macrophage colony-stimulating factor (M-CSF) may play an
important role in this process (Frangogiannis et al., 1998).
Macrophage accumulation in the healing heart is regulated by
the renin-angiotensin-aldosterone system. Angiotensin II (ATII)
allows deployment of myelomonocytic cells via the ATII recep-
tor type 1 (AT1R) from the spleen and directs them to the
inflamed tissue (Swirski et al., 2009). ATII leads to release
of the mineralocorticoid aldosterone from the adrenal glands.
Aldosterone has pro-inflammatory effects via its mineralocorti-
coid receptor (MR) on cardiomyocytes. Selective MR blockade
immediately after MI improved healing (Frantz et al., 2009), an
effect that was blunted by macrophage depletion (Fraccarollo
et al., 2008). Cardiomyocyte specific genetic ablation of the MR
improved healing, partially via increased RANTES/CCR5 depen-
dent chemotaxis of myelomonocytic cells supporting healing
(Fraccarollo et al., 2011). This indicates, that recruitment of
inflammatory cells not necessarily impairs healing, but is pos-
sibly also required to kick off the outbalanced sequence of cel-
lular events involved in healing. Indeed, mice that were either
chemically or genetically depleted of inflammatory myelomono-
cytic cells, died from cardiac rupture and atherothrombosis
propably due to impaired wound healing (Frantz et al., 2013).
The beneficial impact of macrophages on remodeling can par-
tially be assigned to the release of soluble lipid mediators
like resolvins, lipoxins and maresins. These factors have been
shown to contribute to resolution of inflammation in general
(Serhan, 2010). In ApoE−/− mice fed a high fat diet, failure
to form the inflammation-resolving lipids lipoxin A4,resolving
D1 and protectin D1 accelerated atherosclerosis progression,
while macrophage-specific overexpression of 12/15 lipoxygenase
reduced atherosclerotic burden via the formation of these medi-
ators (Merched et al., 2008). If resolution of MI related cardiac
injury is improved by these mediators remains to be tested.
MUTUAL ACTIVATION OF NK CELLS AND MONOCYTES IN VASCULAR
DYSFUNCTION
Besides CD8+ T cells and T-bet+CD4+ T cells, Natural Killer
(NK) cells are a major source of IFN-γ. In type 1 inflammatory
immune responses including atherosclerosis and acute phase of
MI, IFN-γ is known to play a major role in activating mono-
cytes and macrophages (Boehm et al., 1997; Schroder et al.,
2004) and driving them toward inflammatory phenotype (e.g.,
M1 macrophages or Ly6Chi monocytes) (Abbas et al., 1996).
NK cells are key players in the innate immune response and
produce a variety of cytokines such as IL-1beta, tumor necrosis
factor alpha (TNFα), and IFN-γ and thereby participate in reg-
ulating innate and adaptive immunity (Yokoyama et al., 2004;
Shereck et al., 2007). They represent a specialized lymphoid pop-
ulation, and act in an activating and inhibiting way by expressing
different receptors (Moretta and Moretta, 2004). NK cells and
monocytes/macrophages undergo reciprocal patterns of activa-
tion, that include receptor based cell-cell-contact triggered path-
ways mainly via CD154-CD40, 2B4, and NKG2D interactions
and NKp46 conserved in a variety of species including mouse
and human (for review, please see Michel et al., 2012). Of note,
natural killer cell activation is in many aspects unique in humans
as compared to mice, and even mice strains differ in the expres-
sion of certain surface markers and clusters of differentiation,
like NK1.1, which is only found in C57BL/6 mice. In contrast,
macrophage/NK cell interactions through soluble factors does not
necessarily require cell-cell-contact for efficient signaling, which
has gained growing attention in recent years. In a seminal work,
Interleukin 12 (IL-12) was identified as the natural killer cell
stimulatory factor (D’andrea et al., 1992) released by activated
monocytes. Shortly thereafter, IL-12 and TNF-α released by acti-
vated macrophages were identified to be powerful inducers of
IFN-γ by NK cells (Tripp et al., 1993).
It has been identified that macrophages can activate NK cells
by producing interleukins such as IL-12 or IL-18 or through
direct cell-to-cell contact (Aranha et al., 2005; Atochina andHarn,
2005). On the other side NK-cell-derived IFN-γ plays an impor-
tant role in initializing the differentiation of monocytes into
macrophages or dendritic cells, which are producers of IL-15, IL-
12, and IL-18 (D’andrea et al., 1992; Welte et al., 2006; Goldszmid
et al., 2012). By synergizing of IL-12 with IL-18, production of
IFN-γ in NK cells increases, which is due to a positive feedback
loop that represent an important mechanism in the early innate
inflammatory response.
Mice deficient in the helix-loop-helix transcription factor
inhibitor of differentiation (Id2(–/–)) which lack Langerhans
cells, are defective in CD8+ T cells and dendritic cells as well
as NK cells, were partially protected from ATII induced hyper-
tensive damage. However, a clearcut effect of NK cells in this
setting could not be delineated from these findings (Gratze et al.,
2008). Interestingly, monocytes depend on T-bet for production
of IL-12 and therefore for sufficient activation of NK cells to
release IFN-γ (Soderquest et al., 2011). Kossmann et al. could
recently show that angiotensin II-induced vascular dysfunction
depends on vascular entry and IFN-γ production by NK cells.
They identified IFN-γ was produced by NK cells in the aortic wall
which initiate vascular oxidative stress, inflammatory cell recruit-
ment and reciprocal innate immune cell activation in the vessel
wall. In addition, T-bet deficient monocytes were not capable
to induce ATII-dependent immune cell influx and NK-cell acti-
vation and depletion of NK-cells lead to protection from AT-II
induced vascular dysfunction (Kossmann et al., 2013). This effect
was equivalent to the effect of myelomonocytic cell depletion in
LysMiDTR mice in the same model of arterial hypertension that
had been reported before (Wenzel et al., 2011), highlighting the
importance of NK cell/monocyte interaction and mutual activa-
tion for induction and maintenance of vascular inflammation.
More evidence supporting the importance of NK cells for vascu-
lar dysfunction was demonstrated by introducing theNK cell gene
complex derived form C57BL/6 mice into the genome of BALB/C
mice, rendering the strain as succeptible to vascular injury as the
C57BL/6 mice in a hypertension model (Taherzadeh et al., 2010)
and in a balloon injury model (De Vries et al., 2013).
Neither it is known, how these findings extrapolate to the
situation in acute MI, nor if NK cells preferentially cooperate
with Ly6Chi (proinflammatory) or Ly6Clo monocytes in vascular
inflammation. Most pathways triggering an activating pattern of
communication between NK cells and monocytes are hallmarked
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by TLR-ligands and proinflammatory cytokines like TNF-α, IFN-
γ, IL-12, and IL-18 (Kloss et al., 2008; Vivier et al., 2008; Michel
et al., 2012). This suggests, that NK cells preferentially cooperate
with proinflammatory myelomonocytes in vascular inflamma-
tion and MI, or at least skews these cells toward this phenotype.
This hypothesis, however, remains to be tested.
INTERACTION OF NK CELLS AND MONOCYTES IN
CORONARY ARTERY DISEASE AND MYOCARDIAL
INFARCTION
Little is known about the interaction of NK cells and mono-
cytes/macrophages in the setting of atherosclerosis or acute MI.
It was shown that NK cells are present in atherosclerotic plaques
in humans as well as in mice (Whitman et al., 2004; Bobryshev
and Lord, 2005), but the in vivo role of these immune cells in
(coronary) atherosclerosis and MI is incompletely understood.
It was shown ex vivo that NK cells produce more IFN-γ fostered
by the CD48-2B4 axis (Figure 2) when co-cultured with mono-
cyte derived dendritic cells, that had been exposed to oxidized
LDL (Dong et al., 2011). This finding can at least in part explain
the proatherogenic effects of NK cells.
Different research groups described a reduced NK cell activity
in patients with CAD in comparison to healthy subjects (Jonasson
et al., 2005; Hak et al., 2007). This effect was much more pro-
nounced in patients in unstable conditions or acute coronary
syndrome (Backteman et al., 2012; Hou et al., 2012).
NK cells show a biological variation over time and in a recently
published 12-month follow-up study of patients with a coronary
FIGURE 2 | Vascular inflammation, NK cell/monocyte crosstalk and
angiotensin II in cardiac ischemic injury. In cardiac ischemia
reperfusion injury and remodeling after MI, vascular inflammation
plays a central role. Monocytes transmigrate into the infarcted zone
and transdifferentiate into macrophages, that can exert various
functions in remodeling depending on the microenvironment provided
by cytokines (e.g., IL-12, IL-18, IFN-γ), chemokines (e.g., RANTES/
CCL5, MCP-1/CCR2), integrins (e.g., VCAM-1, ICAM-1) and soluble
lipid factors like resolvins, lipoxins, and maresins. Signaling through
angiotensin II and its downstream hormone aldosterone plays a
central mechanistic role in this process. It leads to deployment of
AT1R+ monocytes from the spleen to the infarcted area, increases
(in red) or attenuates (in blue) chemokine and cytokine expression
from the endothelium and from leukocytes, fosters monocyte
transmigration and -differentiation and supports a reciprocal program
of activation between NK cells and monocytes. While parts of this
crosstalk have been partially investigated in this setting (e.g., the
T-bet/IFN-γ/IL-12 pathway), most aspects of mutual NK cell/monocyte
activation are not known in the setting of vascular inflammation and
cardiac ischemic injury. This includes interaction between CD40 and
CD154 (Bellora et al., 2010), CD48 and 2B4 (Nedvetzki et al., 2007)
and NKG2D and retinoic acid inducible-1 (RAI-1) or members of the
MHC class-I related chain (MIC) family of proteins, like MICA
(Hamerman et al., 2004; Kloss et al., 2008). All of these are known
to increase IFN-γ production by NK cells and CD69 expression on
NK cells in infection or lipopoplysaccharide-driven models.
Abbreviations: CD, cluster of differentiation; IL, interleukin; ATII,
angiotensin II; AT1R, ATII receptor type 1; MR, mineralocorticoid
receptor. Red letters: induced/activated by ATII/Aldosterone. Blue
letters: attenuated by ATII/Aldosterone.
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event, no evidence was found that reduction of NK cells was asso-
ciated with aberrations in NK cells cell phenotype at any clinical
stage of the disease. However, failure to reconstitute NK cell
levels was associated with a persistent low-grade inflammation,
suggesting a protective role of NK cells in CAD (Backteman et al.,
2012). The mechanism why there is a deficit of NK cells in CAD
is not identified yet, but an increased apoptosis of these cells in
CAD patients has been reported (Li et al., 2008). On the other
side data from experimental studies demonstrated that NK cells
infiltrate the vessel wall and promote atherosclerotic lesion devel-
opment (Whitman et al., 2004). A recently published work of
Selathurai and coworkers demonstrated evidence that NK cells
are atherogenic and their production of perforin and granzyme B
contributes to atherosclerosis and the expansion of necrotic cores
(Selathurai et al., 2014) representing vulnerable lesions prone for
atherothrombosis as in MI.
RAAS signaling might play an important role in promoting
mutual activation of NK cells and myelomonocytic cells, given its
key role in hypertension, atherogenesis and MI (summarized in
Figure 2). Expression and activity of many chemokines, integrins
and cytokines and its receptors (e.g., MCP-1/CCR2, IFN-γ/IFN-
γR, VCAM-1/VLA-4) as well as pro-atherogenic enzymes (e.g.,
NADPH oxidase) were shown to be driven by ATII/aldosterone
on monocytes and the vessel, but not yet on NK cells, although
their battery of signaling structures (e.g., CCR2, CCR5, LFA-1,
VLA-4) share many similarities with monocytes (Figure 2).
CONCLUSION
Natural killer cells and monocytes/macrophages with their
mutual programs of interactions are an important asset to the
innate immune response. Its role in vascular inflammation,
atherosclerosis, coronary artery disease and MI is now starting
to catch interest from immunologist and vascular biologist (for
scheme, see Figure 2). The molecular and physiologic interac-
tions are nevertheless poorly explored and incompletely under-
stood, although some potential targets have arisen from experi-
mental research, that might be attractive for therapeutic targeting.
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